- Home
- HRTX vs CLPR Comparison
HRTX vs CLPR Comparison
Compare HRTX & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRTX | CLPR |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 51.2M |
| IPO Year | 2007 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HRTX | CLPR |
|---|---|---|
| Price | $0.30 | $3.11 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 35.1K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 12.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $154,904,000.00 | $109,997,000.00 |
| Revenue This Year | N/A | $0.91 |
| Revenue Next Year | N/A | $2.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.36 | 5.82 |
| 52 Week Low | $0.26 | $2.69 |
| 52 Week High | $1.58 | $4.20 |
Technical Indicators
Market Signals| Indicator | HRTX | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 40.45 | 41.72 |
| Support Level | $0.29 | $3.03 |
| Resistance Level | $0.34 | $3.54 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 8.20 | 24.39 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.